Mrs. Christina R Diesen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 231 N Main St, Breese, IL 62230 Phone: 618-322-6424 Fax: 618-227-8227 |
Fred Charles Boch, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9401 Holy Cross Ln, Suite 112, Breese, IL 62230 Phone: 618-526-7271 Fax: 618-526-7313 |
Renee Keller, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10551 Vonder Haar Ln, Breese, IL 62230 Phone: 618-520-3339 |
News Archive
Increased vascular stiffness has been identified as an important part of hypertension in aging adults. Previous studies of aortic stiffness have focused on changes in structural proteins that alter the properties of vascular walls causing them to become rigid.
Watson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its trospium chloride extended-release 60 mg capsules prior to the expiration of a patent owned by Supernus Pharmaceuticals, Inc.
President Obama summed up our debt crisis best when he told Republican members of the House in January 2010 that "The major driver of our long-term liabilities ... is Medicare and Medicaid and our health care spending." A few months later, however, Mr. Obama and his party's leaders in Congress added trillions of dollars in new health-care spending to the government's balance sheet.
Researchers at Moffitt Cancer Center are in the first phase of creating "designer lymph nodes." Designer lymph nodes are built with specialized gene-modified cells that are injected into patients and produce a pre-planned immunologic response for cancer patients locally and then throughout their bodies. The researchers are examining a cancer vaccine "boosting" effect of the manufactured lymph nodes in patients with advanced melanoma.
"U.S. government officials say they expect to put the finishing touches this month on new rules designed to help funding agencies identify and regulate especially problematic H5N1 studies before they begin," which would allow influenza researchers "to lift a year-old, self-imposed moratorium on certain kinds of potentially dangerous experiments," Science reports.
› Verified 4 days ago